Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and efficacy of IMG-007 in adults with alopecia areata has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• IMG-007

Snippet

Sponsor: Inmagene LLC | Conditions: Alopecia Areata (AA) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-02-09